News Release
Archive - New Contact Information
For more information about this archival news release, please contact Christine Flowers, Director, Office of Communications & Public Liaison at (919) 541-3665.
FOR IMMEDIATE RELEASE
Tuesday, October 4, 2005, 12:00 p.m. EDT
Tuesday, October 4, 2005, 12:00 p.m. EDT
Contact: Robin Mackar,
NIEHS
(919) 541-0073
(919) 541-0073
← Back to Page
| What: | An independent panel of 11 scientists convened by the Center for the Evaluation of Risks to Human Reproduction (CERHR), of NIEHS and National Toxicology Program, will review recent scientific data and reach conclusions regarding whether or not exposure to DEHP (di (2-ethylhexyl) phthalate) is a hazard to human development or reproduction. The 2.5 day meeting is open to members of the public and the media. A press availability period will immediately follow the meeting at approximately noon on October 12th. |
| When: | Monday, October 10, 2005, 8:30 a.m. - 5:00 p.m. Tuesday, October 11, 8:30 a.m. - 5:00 p.m. Wednesday, October 12, 8:30a.m.- noon Press Availability: Wednesday, October 12, approximately 12-1p.m. |
| Where: | Carlyle Room, 5th floor Holiday Inn Old Town, 480 King Street, Alexandria, VA 22314 Tel: 1-703-549-6080 Fax: 1-703-684-6508 http://www.ihg.com/hotels/us/en/reservation (http://www.ichotelsgroup.com/h/d/hisl/1/en/hd/axeot) |
| Why: | A wide variety of consumer products including cosmetics, building and car materials, clothing, food packaging, some children's toys, and even some medical devices often contain chemicals referred to as phthalates. Phthalates are added to plastics to increase their flexibility. DEHP (di (2-ethylhexyl) phthalate), which is used to make some medical tubing and other devices, has been shown in animal studies to be hazardous at high levels of exposure. Vulnerable populations such as critically ill newborns may be exposed to higher levels than the general population due to the extensive medical procedures they undergo. Since the review of DEHP by a CERHR expert panel in 2000, approximately 150 new papers relevant to this evaluation have been published. Therefore there is a need to conduct an updated evaluation of the potential toxicities of DEHP. The draft report is available for review at http://ntp.niehs.nih.gov/ntp/roc/content/profiles/diethylhexylphthalate.pdf. |
| Background: | The Center for the Evaluation of Risks to Human Reproduction (CERHR) was established by NIEHS as part of the National Toxicology Program in 1998. The CERHR convenes a scientific expert panel that meets in a public forum to review, discuss, and evaluate the scientific literature on a selected chemical. CERHR selects chemicals for evaluation based upon several factors including production volume, extent of human exposure, public concern, and the extent of published information on reproductive or developmental toxicity. NTP is an HHS program established in 1978 that is headquartered at NIEHS, a part of the National Institutes of Health. NIEHS Director, Dr. David A. Schwartz, serves as NTP Director. |
| Registration: | No registration is required. Members of the press interested in attending or conducting on-site or phone interviews with any of the scientists, please contact Robin Mackar at (919) 541-0073 or by email at rmackar@niehs.nih.gov. She will schedule interviews for the press availability period immediately following the meeting. Details about the meeting, including panelists and agenda, are posted on the NTP website http://cerhr.niehs.nih.gov/news/fedreg.html. |
About the National Institute of Environmental Health Sciences (NIEHS): NIEHS supports research to understand the effects of the environment on human health and is part of the National Institutes of Health. For more information on NIEHS or environmental health topics, visit www.niehs.nih.gov or subscribe to a news list.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH...Turning Discovery Into Health®
to Top